Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PEANUT
- E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
- Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
- Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts
- Phase 1b/2a of CNP-201 in Subjects With Peanut Allergy
- Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy
- Preventing Anaphylaxis With Acalabrutinib
- Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy
- Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
- Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
- Oral Health-related Quality of Life and Masticatory Function After Using Denture Adhesive and Denture Liner
- Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
- A Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut.
- Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and Malnutrition
- Food Oral Immunotherapy for Peanut Allergy
- Oral Immunotherapy for Peanut Allergic Patients
- Boiled Peanut Oral Immunotherapy
- Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)
- Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
- Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein D
- Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- Clinical Study Using Biologics to Improve Multi OIT Outcomes
- Peanuts and Glycemic Control
- Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma
- A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
- A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
- Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
- Salvage Peanut Oral Immunotherapy Study
- Multi OIT to Test Immune Markers After Minimum Maintenance Dose
- Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
- HAL-MPE1 Safety and Tolerability Study
- Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
- Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy
- E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy
- A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membra
- High Threshold Peanut Challenge Study
- Vaginal Progesterone in Twin With Short Cervix
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients
- Multi Immunotherapy to Test Tolerance and Xolair
- Preschool Wheeze: Inflammation/Infection Guided Management
- Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
- FARE Peanut SLIT and Early Tolerance Induction
- Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation
- HAL-MPE1 First-in-human
- The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery
- Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition
- Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers
- Progesterone and Brain Imaging Study
- Walnut Oral Immunotherapy for Tree Nut Allergy
- The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
- Oral Peanut Immunotherapy for Peanut Allergic Patients
- Mechanisms of Desensitization During Peanut Oral Immunotherapy
- Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
- Tolerance Following Peanut Oral Immunotherapy
- Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
- Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
- Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
- Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova
- Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
- Oral Peanut Immunotherapy
- Xolair Enhances Oral Desensitization in Peanut Allergic Patients
- Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
- Trichuris Suis Ova in Peanut and Tree Nut Allergy
- Omalizumab in the Treatment of Peanut Allergy
- Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
- Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
- Oral Immunotherapy (OIT) for Peanut Allergy
- Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
- A Study of Sublingual Immunotherapy in Peanut-allergic Children
- A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
- A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g
- Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana
- A Safety and Efficacy Study of Xolair in Peanut Allergy
Clinical trials list
click for details